Tuberous sclerosis (TSC) is an autosomal dominant disorder caused by a mutation in either the TSC1 or TSC2 tumour suppressor gene. The disease is characterized by a broad phenotypic spectrum that can include seizures, mental retardation, renal dysfunction and dermatological abnormalities. TSC2 encodes tuberin, a putative GTPase activating protein for rap1 and rab5. The TSC1 gene was recently identified and codes for hamartin, a novel protein with no significant homology to tuberin or any other known vertebrate protein. Here, we show that hamartin and tuberin associate physically in vivo and that the interaction is mediated by predicted coiled-coil domains. Our data suggest that hamartin and tuberin function in the same complex rather than in separate pathways.
INTRODUCTION
Tuberous sclerosis (TSC) is characterized by the widespread development of hamartomatous growths in many tissues and organs. The brain, eyes, kidneys, heart and skin are frequently affected, but the lungs, skeleton and endocrine glands may also be involved (1) . The lack of clues as to cellular functional abnormalities has meant that efforts to identify the primary underlying defect in TSC patients have focused on positional cloning.
TSC is genetically heterogeneous, with loci on chromosomes 9q34 (TSC1) and 16p13.3 (TSC2) (2) . The TSC2 gene was isolated in 1993 (3) and codes for tuberin, a 200 kDa (1807 amino acid) protein. Tuberin contains a relatively hydrophobic N-terminal domain (4) and a conserved 163 amino acid region close to the C-terminus, which is homologous to the GTPase activating proteins (GAP) rap1GAP and mSpa1 (5) .
The TSC1 gene was recently identified (6) and codes for hamartin, a 130 kDa (1164 amino acid) hydrophilic protein with no significant homology to tuberin or other known vertebrate proteins.
We tested whether hamartin and tuberin could interact using the yeast two-hybrid system (7) and transfection assays. Furthermore, in human cells in culture, we investigated the association between endogenous hamartin and tuberin by coimmunoprecipitation. Our data demonstrate that hamartin and tuberin associate physically in vivo suggesting that both proteins play a closely related role in an as yet undetermined physiological process.
RESULTS

The predicted coiled-coil domain in hamartin interacts with a putative coiled-coil domain in tuberin
The predicted amino acid sequences of hamartin and tuberin were analysed for potential interaction domains. COILS version 2.1 (8) identified a more extensive coiled-coil structure in hamartin than reported previously (6) (amino acids 719-998, window size 28) (Fig. 1a) , while a less stringent analysis (window size 14) of the original tuberin sequence (3) predicted two coiled-coil domains at amino acid positions 346-371 and 1008-1021 (Fig. 1a) . As coiled-coil domains have the capacity to form homophilic and heterophilic protein complexes (8) , these domains were made the focus of subsequent yeast two-hybrid experiments.
A construct coding for tuberin (amino acids 1-1784) (3) fused to the GAL4 DNA-binding domain was tested against constructs coding for the GAL4 transactivating domain fused to the N-terminal (XB1, amino acids 23-357) and C-terminal (EE1a, amino acids 334-1153) domains of hamartin (Fig. 1b) . A strong, specific interaction was detected between tuberin and EE1a, containing the C-terminal, putative coiled-coil domain of hamartin. No interaction was detected between tuberin and the N-terminal domain of hamartin. Self-activation of GAL4 activity was not observed for any of the constructs used in this study.
To define the binding domain within hamartin more precisely, a series of truncated constructs was analysed (Fig. 1b) . Only construct ESA (amino acids 334-673), lacking the entire coiled-coil domain, did not interact with tuberin. Construct EE2 (amino acids 334-788) tested positive, suggesting that the first seven heptad structures in the coiled-coil domain were sufficient for hamartin to interact with tuberin.
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The interaction domain in tuberin was also defined using partial constructs (Fig. 1c) . A potential leucine zipper (amino acids 81-121), the two putative coiled-coil domains (amino acids 346-371 and 1008-1021) and a deletion construct (GRD; amino acids 1-41 and 861-1784) containing the GAP-related domain were tested against the EE1 (amino acids 334-1153) hamartin construct. Only the most N-terminal coiled-coil construct (amino acids 346-371) tested positive. The specificity of the coiled-coil interaction was investigated in the two-hybrid assay using another coiled-coil containing protein, giantin (9), against hamartin and tuberin. No GAL4 activation occurred (data not shown), indicating that the interaction detected between the coiled-coil domains in hamartin and tuberin was specific.
Hamartin and tuberin colocalize in transfected mammalian cells
In order to confirm the two-hybrid results, the localization of hamartin and tuberin in transfected cells was studied using immunofluorescent microscopy. A full-length TSC1 cDNA in the pcDNA3.1 expression vector was transfected into COS cells. A distinct labelling pattern was observed, consisting of discrete structures in the cytoplasm ( Fig. 2A) . In contrast, expression of an epitope tagged full-length TSC2 construct produced a general cytoplasmic labelling pattern (Fig. 2B) . When COS cells were cotransfected with the TSC1 and TSC2 construct, both hamartin and tuberin localized to the same structures as well as to the cell cytoplasm ( Fig. 2C-E) . Untransfected COS cells did not stain with the hamartin-and tuberin-specific antisera. Similar results were obtained in transfected HeLa and CHO cells (data not shown). To investigate whether the colocalization was due to overexpression of hamartin and tuberin, several control proteins including the fragile X mental retardation protein, acid α-glucosidase and the C-terminal domain of polycystin, containing a predicted coiled-coil structure (10), were co-expressed with hamartin in COS cells. None of the controls colocalized to the hamartin positive structures, confirming that the colocalization of hamartin and tuberin was specific.
Hamartin and tuberin coimmunoprecipitate in vivo
In order to investigate whether the observed association between hamartin and tuberin also occurred in vivo, the endogenous proteins were immunoprecipitated from HeLa cells and cultured human fibroblasts. Hamartin could be recovered from the immunoprecipitates of antisera specific for tuberin, while tuberin coimmunoprecipitated with hamartin when an antiserum specific for hamartin was used (Fig. 3) . Identical results were obtained with different anti-hamartin and anti-tuberin antisera (data not shown). Preimmune sera and a control antiserum (against human acid α-glucosidase) were negative, demonstrating that the observed coimmunoprecipitation of tuberin and hamartin was specific, and confirming that the association detected by the two-hybrid assay occurs in mammalian cells.
DISCUSSION
To investigate the molecular mechanism underlying TSC, we tested for an interaction between tuberin and hamartin using three independent methods. In each case, we showed that the proteins are partners. In view of the phenotypic overlap observed between TSC patients with either a TSC1 or TSC2 mutation, this suggests that inactivation of hamartin or tuberin may prevent the formation of a functional protein complex. A comparable scenario has been reported recently for the PKD1 and PKD2 proteins (10, 11) . However, unlike polycystin 1 and 2, no regions of homology between tuberin and hamartin have been detected (6) .
The interaction between tuberin and hamartin is mediated by potential coiled-coil domains. A predicted N-terminal coiled-coil domain in tuberin interacts with only a small part of an extensive Figure 3 . In vivo coimmunoprecipitation of tuberin and hamartin. Tuberin and hamartin were immunoprecipitated from fibroblast lysates with tuberinspecific antiserum (lanes 1 and 6), hamartin-specific antiserum (lanes 2 and 7) and an antiserum against human acid α-glucosidase (lanes 3 and 8) . Lanes 4 and 9 contain the lysate prior to immunoprecipitation. The molecular weight marker is in lane 5 (from top to bottom: 230, 100, 80 kDa). Lanes 1-4 were incubated with anti-tuberin antibody, and lanes 6-9 with anti-hamartin antibody. IgG heavy chains (50 kDa) are visible in lanes 1-3 and 6-8. The additional lower molecular weight bands in lane 9 are probably degradation products of hamartin, not consistently observed (data not shown).
coiled-coil region in hamartin. Preliminary results indicate that the coiled-coil domain in hamartin can form a homophilic complex (data not shown). We are currently investigating whether the additional coiled-coils in hamartin mediate interactions with additional proteins important in the pathogenesis of TSC.
Overexpression of hamartin in COS cells showed a distinct labelling pattern in the cytoplasm, while tuberin produced a general cytoplasmic labelling. When hamartin and tuberin were cotransfected in mammalian cells, tuberin was recruited in a specific manner to the hamartin positive structures and the proteins colocalized more generally in the cytoplasm. These data, together with the in vivo association of hamartin and tuberin detected by coimmunoprecipitations, support the results of the two-hybrid system and provide strong evidence that hamartin and tuberin exist as a complex.
Recently, it has been demonstrated by the two-hybrid system that the C-terminal part of tuberin interacts with rabaptin-5 (12). Rabaptin-5 is a 115 kDa cytosolic protein that is an effector for the endosomal small GTPase rab5 and therefore involved in endocytic fusion events (13) . Consistent with the tuberinrabaptin-5 interaction, tuberin has been shown to act as a GTPase activating protein for rab5, and to reduce the rate of fluid-phase endocytosis (12) . It will be important to establish whether binding between hamartin and tuberin regulates the rab5 GAP activity of tuberin and to investigate the effect of hamartin expression on fluid-phase endocytosis and early endosome fusion. We are currently investigating the nature of the hamartin-containing structures detected in the transfection experiments. It is possible that the identification of additional endosomal proteins that interact with either hamartin, tuberin or both may help to clarify whether dysregulation of endocytosis is important in the aetiology of TSC.
MATERIALS AND METHODS
TSC1 and TSC2 constructs
A full-length TSC2 cDNA (nucleotides 1-5474) was derived from previously identified partial cDNAs (3) and cloned into the pGBT9 (Clontech) and pcDNA3.1HisA (Invitrogen) vectors. The TSC2 C-terminal GAP domain construct (GRD) was made by digestion with SacII, leading to an in-frame deletion of amino acids 42-860. The full-length TSC1 cDNA was amplified by RT-PCR with oligonucleotides 5′-TGAGGTAAACAGCT-GAGGGG-3′ and 5′-AAGGTCAAGAGGCATTTCAA-3′ and cloned into pGEM-T Easy (Promega) and subsequently into pcDNA3.1. The remaining TSC1 and TSC2 constructs were derived by PCR, using primers with linkers for direct restriction site cloning. pAD26, pAD10 and LeuZip were amplified from a TSC2 cDNA clone using the primer pairs 5′-CTCGAATTC-CACGCAGTGGAAGCACTCTG-3′ and 5′-CTCGGATCCG-GAAGGGTAATCCTTGATGACC-3′ for LeuZip, 5′-GGAAT-TCCAGACGTCCCTCACCAGTGC-3′ and 5′-GCTCTAGAA-GCCGTGAAGTTGGAGAAGA-3′ for pAD26, 5′-GGAATTC-GAGATCGTCCTGTCCATCAC-3′ and 5′-GCTCTAGACG-CACATCTCTCCACCAGTT-3′ for pAD10. The TSC1 deletion constructs were amplified by RT-PCR with the primer pairs 5′-CCCGGGGGACGACGTGACAGCTGTCTTT-3′ and 5′-CC-CGGGGAGTGGTCATACCACAAACCAT-3′ for XB1, 5′-GGA-TCCCATGATGAGTCTCATTGTAGTC-3′ and 5′-GGATCC-GACACGGCTGATAACTGAACCA-3′ for EE1a, 5′-GGATC-CTCATGATGAGTCTCATTGTAGT-3′ and 5′-GGATCCCGA-CACGGCTGATAACTGAACCA-3′ for EE1b. pAD26 and pAD10 were cloned into pAD-2.1 (Stratagene), LeuZip and EE1b into pGBT9 (Clontech) and XB1 and EE1a into pGADGH (Clontech). Three deletion constructs (ESM, EE2 and ESA) were generated using internal restriction sites (SmaI, EcoRI and SalI, respectively). All constructs were checked by sequencing and, where appropriate, by in vitro coupled transcription-translation assay (TnT system; Promega).
Yeast two-hybrid assay
Yeast host strain (YGH1) was cotransformed with 2.5 µg of each plasmid according to the SBEG method (14) . Transformants were plated on minimal media lacking Trp and Leu. After 3 days, three colonies per interaction were plated on media lacking His, Trp and Leu, and growing colonies were tested for β-galactosidase activity with the filter assay.
Generation of tuberin-and hamartin-specific antisera
Two fusion proteins containing N-terminal histidine tag sequences and amino acids 1535-1784 from tuberin and 543-1087 from hamartin were overexpressed in bacteria and affinity purified under denaturing conditions according to the manufacturer's protocol (Qiagen Gmbh). The final eluates were concentrated through an Amicon PM-10 filter and dialysed against phosphate-buffered saline. New Zealand white rabbits were immunized with 150 µg of purified fusion protein suspended in Freund's complete adjuvant, and boosted at 4-week intervals with 150 µg fusion protein in Freund's incomplete adjuvant. Serum was collected 10 days after injection of the immunogen. The resulting polyclonal sera were checked for specificity by western blot and transfection experiments.
Immunofluorescence
Expression constructs were transfected into COS cells with lipofectamine, as recommended by the manufacturer (Gibco BRL). For immunocytochemistry, cells were fixed in 3% paraformaldehyde (10 min, room temperature), quenched with 50 mM NH 4 Cl (10 min) and permeabilized in 0.1% Triton X-100 (5 min). Cells were incubated with primary antibodies, followed by fluorescein (FITC)-or Texas Red (TRITC)-coupled secondary antibodies. Images were captured using the Power Gene FISH system on a Leica DM RXA microscope. Images were processed using a filter wheel (Chroma Technology) and the Adobe Photoshop software package. In addition to the polyclonal sera against hamartin and tuberin, generated as part of this study, antibodies against FMRP, polycystin and α-glucosidase were used for control experiments.
Coimmunoprecipitations
Washed cells (one 10 cm plate) were lysed in 700 µl TNE buffer (40 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5% Nonidet P-40 containing 0.2 mM PMSF), according to standard procedures (15) and cleared by centrifugation (10 000 g, 10 min, 4_C). The supernatant was recovered and incubated with 2 µl antisera for 60 min on ice before the addition of 30 µl 50% protein A-Sepharose suspension. After gentle rotation for 60 min at 4_C, the immunoprecipitates were washed extensively with TNE buffer. Immunoblotting was performed according to standard procedures (15) and coimmunoprecipitating proteins were detected using the appropriate antibodies and enhanced chemiluminescence (Amersham).
